What is the purpose of the study?
This study hopes to test the use of repetitive transcranial magnetic stimulation (rTMS), a new, noninvasive form of brain stimulation treatment, in reducing cannabis craving and consumption. By participating, you would help us develop an effective treatment for those struggling with excessive cannabis use. You will be provided compensation during the study.
Who is needed?
- Individuals who are regular cannabis users interested in reducing or quitting cannabis use
Age range: 18 - 65
Gender: All
Ethnicity: All
What does the study involve?
- Number of contacts: 24
- Time period: 2 months
- Length of contacts: 30 mins - 2 hours
- Treatment offered: Yes
Study Location(s):
1001 Queen St. West (Queen site), Temerty Centre, Unit 4-1
33 Russell St. , BACDRL Lab, Rm. 1910a
Investigator(s): Dr. Victor Tang
Contact Information:
- Phone: 416-535-8501 ext.31553
- E-mail: rtms.cannabis@camh.ca
- Recruitment Flyer Link
Study End Date: 31 May 2025
REB number: 233/2022
Full Study Title: Development of a Novel, Scalable, Neurobiologically-Guided Transcranial Magnetic Stimulation Protocol for the Treatment of Cannabis Use Disorder
PLEASE NOTE:
- Research staff cannot give medical advice over the phone.
- If you have specific questions regarding your health care, please contact your family physician.
- We regret that not everyone screened for a study will be eligible to participate
- For more information about other treatment options for mental illness or addiction offered by CAMH, visit www.camh.ca or call 416-535-8501.